What is perimenopause, really?
Perimenopause is the multi-year transition leading up to a woman's final menstrual period. The average length is four years, but it can stretch to a decade.[1] During this period, ovarian hormone production becomes erratic — estradiol can surge to twice its premenopausal peak one month and drop to post-menopausal lows the next.
These fluctuations drive the symptoms most women associate with menopause: hot flashes, night sweats, sleep disruption, mood changes, brain fog, and irregular cycles. The problem is that menstrual periods often continue throughout — so women are told they are "not menopausal yet" and treatment is deferred.
Why blood tests during perimenopause are tricky
A single FSH or estradiol measurement during perimenopause is almost meaningless. Hormones swing dramatically across days and weeks. A woman could test "premenopausal" on Monday and "menopausal" the following Friday.[2]
This is why expert clinicians rely on a combination of approaches:
- A comprehensive symptom inventory (the Menopause Rating Scale or similar validated tool)
- Multiple hormone measurements across a cycle, not single snapshots
- Other markers that don't fluctuate as wildly — AMH, FSH trend, thyroid panel, vitamin D
- A detailed clinical history including cycle changes, age, family history
What the research says about early intervention
The Women's Health Initiative reanalysis (2017) demonstrated that hormone therapy initiated within 10 years of menopause onset — including the perimenopausal window — has a different risk-benefit profile than therapy initiated decades later.[3] Earlier, individualized intervention is increasingly recognized as a viable option for symptomatic women.
A 2022 NAMS (North American Menopause Society) position statement explicitly endorses hormone therapy as the most effective treatment for vasomotor symptoms and a reasonable option for symptomatic genitourinary changes, with treatment individualized based on each woman's clinical situation.[4]
Why we run a full panel, not just FSH
A meaningful evaluation during perimenopause includes more than a hormone snapshot. We look at the full hormonal picture (estradiol, progesterone, testosterone, DHEA-S, SHBG, FSH, LH) plus systems that are commonly disrupted during the transition: thyroid (TSH, free T3, free T4), metabolic markers (fasting insulin, A1C, lipids), vitamin D, ferritin, and inflammation markers.
This comprehensive view is what separates "your labs are normal" from a real clinical understanding of what may be contributing to your symptoms.
What to do with this information
If you are in your 40s or early 50s and experiencing symptoms consistent with hormonal transition, the right next step is a clinician who takes perimenopausal symptoms seriously and orders comprehensive bloodwork — not just a single FSH. Your evaluation should consider your full clinical picture and the latest evidence on individualized hormone therapy.
